West Pharmaceutical Services Inc. closed 43.99% below its 52-week high of $396.75, which the company achieved on April 8th.

NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West ...

Evercore ISI analyst Daniel Markowitz notes that West Pharmaceutical (WST) shares are down 30% since the company reported Q4 results, but ...

Shares of West Pharmaceutical Services Inc. WST slid 2.63% to $225.80 Tuesday, on what proved to be an all-around favorable ...

With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers. Companies specializing in drug development inputs and services play a crucial role in the ...

West Pharmaceutical Services has a 12-month low of $197.01 and a 12-month high of $397.72. The company has a current ratio of 2.79, a quick ratio of 2.23 and a debt-to-equity ratio of 0.08.

As you can see from the chart above the percentage of shares that are sold short for West Pharmaceutical Servs has grown since its last report. This does not mean that the stock is going to fall ...

A 300-strong South West-based pharmaceutical firm has posted results featuring a surge in turnover and profits. Qualasept, which is based in Wiltshire, supplies pharmaceutical products and services.

BERLIN, March 28, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...